Literature DB >> 8064237

Public and private V beta T cell receptor repertoires against hen egg white lysozyme (HEL) in nontransgenic versus HEL transgenic mice.

R Cibotti1, J P Cabaniols, C Pannetier, C Delarbre, I Vergnon, J M Kanellopoulos, P Kourilsky.   

Abstract

We have previously produced a transgenic mouse line for hen egg lysozyme (HEL), an experimental model for analyzing tolerance to self-antigens at the peptide level. We have now characterized transgenic mice with HEL blood levels below 2 ng/ml, where significant T cell proliferative responses to HEL and its immunodominant peptide were observed. This HEL-low transgenic model was chosen because it mimics physiological conditions in which autoreactive T lymphocytes, recognizing self-components expressed at very low levels, persist without inducing a break in tolerance. Furthermore, in H-2d mice, HEL-specific T lymphocytes are triggered by a single immunodominant region, allowing us to compare the HEL-specific T cell V beta repertoires of transgenic and nontransgenic animals against a single peptide presented as self or foreign, respectively. We found that a V beta 8.2-D beta 1-J beta 1.5 rearrangement is found in response to HEL in all nontransgenic mice, whereas this V beta-restricted response is absent in HEL-low transgenic animals. At the nucleotide level, this rearrangement results from the trimming of the genomic segments during VDJ or DJ joining, without N additions, suggesting that the dominant rearrangement is selected early during fetal or neonatal life, before the expression of terminal deoxynucleotidyl transferase. In HEL-low transgenic mice, no dominant rearrangements are found as alternatives to the one observed in normal mice. Instead, each transgenic animal uses a different set of V beta-J beta combinations in its response to the immunodominant HEL peptide. In nontransgenic mice, besides the dominant V beta 8.2-D beta 1-J beta 1.5 combination, minor V beta repertoires were found which differed in each animal and were distinct from the rearrangements used by individual transgenic mice. These findings suggest that the T cell response to an immunodominant peptide involves a "public" V beta repertoire found in all animals and a "private" one which is specific to each individual.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8064237      PMCID: PMC2191659          DOI: 10.1084/jem.180.3.861

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  41 in total

Review 1.  T-lymphocyte recognition of antigen in association with gene products of the major histocompatibility complex.

Authors:  R H Schwartz
Journal:  Annu Rev Immunol       Date:  1985       Impact factor: 28.527

2.  Correlations between T-cell specificity and the structure of the antigen receptor.

Authors:  P J Fink; L A Matis; D L McElligott; M Bookman; S M Hedrick
Journal:  Nature       Date:  1986 May 15-21       Impact factor: 49.962

3.  T cell tolerance by clonal elimination in the thymus.

Authors:  J W Kappler; N Roehm; P Marrack
Journal:  Cell       Date:  1987-04-24       Impact factor: 41.582

4.  The sizes of the CDR3 hypervariable regions of the murine T-cell receptor beta chains vary as a function of the recombined germ-line segments.

Authors:  C Pannetier; M Cochet; S Darche; A Casrouge; M Zöller; P Kourilsky
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-01       Impact factor: 11.205

5.  A single VH gene segment encodes the immune response to phosphorylcholine: somatic mutation is correlated with the class of the antibody.

Authors:  S Crews; J Griffin; H Huang; K Calame; L Hood
Journal:  Cell       Date:  1981-07       Impact factor: 41.582

Review 6.  Idiotypic regulation in immune networks.

Authors:  J Urbain; C Wuilmart; P A Cazenave
Journal:  Contemp Top Mol Immunol       Date:  1981

7.  Antigen presentation of lysozyme: T-cell recognition of peptide and intact protein after priming with synthetic overlapping peptides comprising the entire protein chain.

Authors:  G S Bixler; T Yoshida; M Z Atassi
Journal:  Immunology       Date:  1985-09       Impact factor: 7.397

Review 8.  Influence of viral superantigens on V beta- and V alpha-specific positive and negative selection.

Authors:  K Tomonari; S Fairchild; O A Rosenwasser
Journal:  Immunol Rev       Date:  1993-02       Impact factor: 12.988

9.  The genetic basis of antibody production: the dominant anti-arsonate idiotype response of the strain A mouse.

Authors:  M Siekevitz; M L Gefter; P Brodeur; R Riblet; A Marshak-Rothstein
Journal:  Eur J Immunol       Date:  1982-12       Impact factor: 5.532

10.  Immunoglobulin diversity: analysis of the germ-line VH gene repertoire of the murine anti-GAT response.

Authors:  C Schiff; M Milili; M Fougereau
Journal:  Nucleic Acids Res       Date:  1983-06-25       Impact factor: 16.971

View more
  54 in total

1.  T cell clonal expansions detected in patients with primary biliary cirrhosis express CX3CR1.

Authors:  Weici Zhang; Yoko Ono; Yoshinori Miyamura; Christopher L Bowlus; M Eric Gershwin; Emanual Maverakis
Journal:  J Autoimmun       Date:  2011-06-01       Impact factor: 7.094

2.  Murine natural killer T(NKT) cells [correction of natural killer cells] contribute to the granulomatous reaction caused by mycobacterial cell walls.

Authors:  I Apostolou; Y Takahama; C Belmant; T Kawano; M Huerre; G Marchal; J Cui; M Taniguchi; H Nakauchi; J J Fournié; P Kourilsky; G Gachelin
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-27       Impact factor: 11.205

3.  Conserved T cell receptor usage in primary and recall responses to an immunodominant influenza virus nucleoprotein epitope.

Authors:  Katherine Kedzierska; Stephen J Turner; Peter C Doherty
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-22       Impact factor: 11.205

4.  An affinity/avidity model of peripheral T cell regulation.

Authors:  Hong Jiang; Yilun Wu; Bitao Liang; Zongyu Zheng; Guomei Tang; Jean Kanellopoulos; Mark Soloski; Robert Winchester; Itamar Goldstein; Leonard Chess
Journal:  J Clin Invest       Date:  2005-02       Impact factor: 14.808

5.  Broad cross-reactive TCR repertoires recognizing dissimilar Epstein-Barr and influenza A virus epitopes.

Authors:  Shalyn C Clute; Yuri N Naumov; Levi B Watkin; Nuray Aslan; John L Sullivan; David A Thorley-Lawson; Katherine Luzuriaga; Raymond M Welsh; Roberto Puzone; Franco Celada; Liisa K Selin
Journal:  J Immunol       Date:  2010-11-03       Impact factor: 5.422

6.  Expansion of a recurrent V beta 5.3+ T-cell population in newly diagnosed and untreated HLA-DR2 multiple sclerosis patients.

Authors:  P Musette; D Bequet; C Delarbre; G Gachelin; P Kourilsky; D Dormont
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-29       Impact factor: 11.205

7.  Cross-reactive influenza virus-specific CD8+ T cells contribute to lymphoproliferation in Epstein-Barr virus-associated infectious mononucleosis.

Authors:  Shalyn C Clute; Levi B Watkin; Markus Cornberg; Yuri N Naumov; John L Sullivan; Katherine Luzuriaga; Raymond M Welsh; Liisa K Selin
Journal:  J Clin Invest       Date:  2005-11-23       Impact factor: 14.808

8.  Escape from highly effective public CD8+ T-cell clonotypes by HIV.

Authors:  Maria Candela Iglesias; Jorge R Almeida; Solène Fastenackels; David J van Bockel; Masao Hashimoto; Vanessa Venturi; Emma Gostick; Alejandra Urrutia; Linda Wooldridge; Mathew Clement; Stéphanie Gras; Pascal G Wilmann; Brigitte Autran; Arnaud Moris; Jamie Rossjohn; Miles P Davenport; Masafumi Takiguchi; Christian Brander; Daniel C Douek; Anthony D Kelleher; David A Price; Victor Appay
Journal:  Blood       Date:  2011-07-06       Impact factor: 22.113

Review 9.  Depletion and dysfunction of Vγ2Vδ2 T cells in HIV disease: mechanisms, impacts and therapeutic implications.

Authors:  Haishan Li; Suchita Chaudhry; Suchita Chaudry; Bhawna Poonia; Yiming Shao; C David Pauza
Journal:  Cell Mol Immunol       Date:  2012-12-17       Impact factor: 11.530

10.  System-wide Analysis of the T Cell Response.

Authors:  Ruxandra Covacu; Hagit Philip; Merja Jaronen; Jorge Almeida; Jessica E Kenison; Samuel Darko; Chun-Cheih Chao; Gur Yaari; Yoram Louzoun; Liran Carmel; Daniel C Douek; Sol Efroni; Francisco J Quintana
Journal:  Cell Rep       Date:  2016-03-10       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.